Searched for
NEUTRAHEALTH PLC
Elder pharmaceuticals eyes Rs 100 crore from global sales of ShelcalElder pharmaceuticals is targeting Rs 100 crore in view of increasing exports base to Europe, Asia and African countries.- Elder Pharma to enter new therapeutics areas to drive growthThe company plans to further strengthen its in-licence portfolio and increase its presence in CNS therapeutic and cardio-vascular segments.
- Elder Pharma to focus on anti-infectives, international marketThe company intends to increase its presence in the UK & Europe through its wholly owned subsidiaries, NeutraHealth PLC & Elder Biomeda EAD...
- Elder Pharma $50 mn QIP issue closesDrug firm Elder Pharmaceuticals today said it has closed its qualified institutional placement (QIP) issue for raising nearly USD 50 millio...
- Elder Pharma up over 5 pc on proposed deal with UK firmShares of Elder Pharmaceuticals soared over five per cent on the Bombay Stock Exchange on Friday, after surging to a year-high, buoyed by t...
- Elder Pharma soars 5 pc on proposed deal with UK firmElder Pharmaceuticals rallied, a day after it made an offer to acquire UK-based NeutraHealth Plc for nearly Rs 70.60 crore.
- Elder Pharma to acquire UK's NeutraHealth for 9.80 mn poundsDrug firm Elder Pharmaceuticals on Thursday said that it has made an offer to acquire UK-based NeutraHealth Plc for nearly 9.80 million pou...
- Elder to launch 8 drugs in CIS, European forayElder Pharma to foray in Commonwealth of Independent States and European market by launching eight drugs in the women healthcare, woundcare...
- Elder Pharma to pick-up 20 pc stake in Neutra HealthElder Pharmaceuticals on Thursday said it will acquire a 20 per cent strategic stake in the UK-based Neutra Health for 5.63 million pounds ...
- Elder Pharma shares up 3% on Neutra buyShares of Elder Pharmaceuticals Ltd gained over 3% on acquiring 20% strategic stake in Neutra Health, an AIM listed company in the United K...
- Elder Pharma acquires 20% stake in NeutraShares of Elder Pharmaceuticals Ltd gained over 3% on acquiring 20% strategic stake in Neutra Health, an AIM listed company in the United K...
Load More- Elder Pharma $50 mn QIP issue closes
